Evaluation of the Combined Treatment Approach "Robin" (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis

被引:7
|
作者
Traber-Walker, Nina [1 ,2 ]
Gerstenberg, Miriam [1 ,2 ]
Metzler, Sibylle [1 ,2 ]
Joris, Maria Raquel [1 ]
Karr, Markus [1 ]
Studer, Nadja [1 ]
Logoz, Marina Zulauf [1 ]
Roth, Alexander [1 ]
Roessler, Wulf [2 ,3 ,4 ,5 ]
Walitza, Susanne [1 ,2 ,6 ,7 ,8 ]
Franscini, Maurizia [1 ,2 ]
机构
[1] Univ Zurich, Dept Child & Adolescent Psychiat & Psychotherapy, Univ Hosp Psychiat, Zurich, Switzerland
[2] Univ Hosp Psychiat Zurich, Zurich Program Sustainable Dev Mental Hlth Serv Z, Zurich, Switzerland
[3] Zurich Univ Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland
[4] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany
[5] Univ Sao Paulo, Lab Neurosci, LIM27, Inst Psychiat, Sao Paulo, Brazil
[6] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Zurich, Switzerland
[8] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland
来源
FRONTIERS IN PSYCHIATRY | 2019年 / 10卷
关键词
psychosis; eMental health; psychological intervention; youth mental health; clinical high risk of psychosis; early intervention; ULTRA-HIGH-RISK; EARLY-ONSET SCHIZOPHRENIA; QUALITY-OF-LIFE; MENTAL-DISORDERS; YOUNG-ADULTS; MOBILE TECHNOLOGIES; EPA GUIDANCE; METACOGNITIVE BELIEFS; HEALTH INTERVENTIONS; FUNCTIONAL OUTCOMES;
D O I
10.3389/fpsyt.2019.00384
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: The prevention of schizophrenia and other psychotic disorders has led researchers to focus on early identification of individuals at clinical high risk (CHR) for psychosis and to treat the at-risk symptoms in the pre-psychotic period. Although at-risk symptoms such as attenuated hallucinations or delusions are common in adolescents and associated with a marked reduction in global functioning, the evidence base of effective interventions for adolescents at CHR state and even first-episode psychosis is limited. Thus, the present protocol describes a study design that combines therapy modules for CHR adolescents with a smartphone application supporting the young individuals between the therapy sessions. The treatment approach "Robin" is based on existing therapy strategies for adolescents with first episode of psychosis and the available recommendations for adults with at-risk symptoms. Methods: The evaluation aims firstly to compare the efficacy of Robin in 30 CHR adolescents aged 14-18 to an active control group (treatment as usual) from a previous study. Primary outcome measures will be at-risk symptomatology, comorbid diagnosis, functioning, self-efficacy, and quality of life. For the prospective intervention condition (16 weekly individual sessions + a minimum 4 family sessions), help-seeking adolescents with CHR for psychosis, aged 14-18, will be recruited over 3 years. At-risk and comorbid symptoms, functioning, self-efficacy, and quality of life are monitored at six time points (baseline, during the treatment period; immediately after intervention; and 6, 12, and 24 months later) and compared with the respective measures of the active control group. Discussion: To the best of our knowledge, this is the first controlled trial to test the efficacy of a specific early psychosis treatment in combination with a smartphone application for adolescents at CHR for developing psychosis. The results of the study are expected to add information that may substantially decrease the burden of CHR adolescents and increase their resilience. It may offer age-adapted and targeted strategies to guide clinicians in the treatment of these vulnerable individuals. Furthermore, research in the field of early intervention will be enriched by our findings.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Clinical high risk for psychosis in children and adolescents: a systematic review
    Tor, Jordina
    Dolz, Montserrat
    Sintes, Anna
    Munoz, Daniel
    Pardo, Marta
    de la Serna, Elena
    Puig, Olga
    Sugranyes, Gisela
    Baeza, Inmaculada
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2018, 27 (06) : 683 - 700
  • [2] Neurocognition and functioning in adolescents at clinical high risk for psychosis
    Mensi, Martina Maria
    Orlandi, Marika
    Casini, Erica
    Catalan, Ana
    de Pablo, Gonzalo Salazar
    Fusar-Poli, Paolo
    Borgatti, Renato
    CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2023, 17 (01)
  • [3] Social network size in adolescents at clinical high risk for psychosis
    Ryan, Patrick C.
    Damme, Katherine S. F.
    Kuhney, Franchesca S.
    Mittal, Vijay A.
    EARLY INTERVENTION IN PSYCHIATRY, 2023, 17 (05) : 462 - 469
  • [4] A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis
    Armando, Marco
    Hutsebaut, Joost
    Debbane, Martin
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [5] Predictors of Outcomes in Adolescents With Clinical High Risk for Psychosis, Other Psychiatric Symptoms, and Psychosis: A Longitudinal Protocol Study
    Molteni, Silvia
    Filosi, Eleonora
    Mensi, Maria Martina
    Spada, Giulia
    Zandrini, Chiara
    Ferro, Federica
    Paoletti, Matteo
    Pichiecchio, Anna
    Bonoldi, Ilaria
    Balottin, Umberto
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [6] Antipsychotic Treatment in People at Clinical High Risk for Psychosis
    Di Lisi, Alessandro
    Pupo, Simona
    Menchetti, Marco
    Pelizza, Lorenzo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (05) : 502 - 508
  • [7] Neurocognition and functioning in adolescents at clinical high risk for psychosis
    Martina Maria Mensi
    Marika Orlandi
    Erica Casini
    Ana Catalan
    Gonzalo Salazar de Pablo
    Paolo Fusar-Poli
    Renato Borgatti
    Child and Adolescent Psychiatry and Mental Health, 17
  • [8] High Stress, Low Resilience in People at Clinical High Risk for Psychosis: Should We Consider a Strengths-Based Approach?
    Drvaric, Lauren
    Gerritsen, Cory
    Rashid, Tayyab
    Bagby, R. Michael
    Mizrahi, Romina
    CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE, 2015, 56 (03): : 332 - 347
  • [9] Sex differences and implications in outcome in children and adolescents at clinical high risk for psychosis
    Tor, Jordina
    Baeza, Inmaculada
    Alvarez-Subiela, Xavier
    Rodriguez-Pascual, Marta
    Munoz-Samons, Daniel
    Sintes-Estevez, Anna
    de la Serna, Elena
    Puig, Olga
    Sugranyes, Gisela
    Ilzarbe, Daniel
    Haro, Josep Maria
    Dolz, Montserrat
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2025,
  • [10] Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder
    Lambert, M.
    Niehaus, V.
    Correll, C.
    PHARMACOPSYCHIATRY, 2016, 49 (06) : 229 - 243